⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

November 29, 2021EClinicalMedicineOpen Access

Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Israel Ministry of Health and Pfizer.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Singer et al. (2021) studied this question.

synapsesocial.com/papers/69e9126354ffb07790260523 https://doi.org/10.1016/j.eclinm.2021.101190

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program — Kentucky, March 2021Original Research · 2021 · 129 citations
2Genetic Variants of SARS-CoV-2—What Do They Mean?Original Research · 2021 · 602 citations
3Neutralizing Activity of BNT162b2-Elicited SerumOriginal Research · 2021 · 538 citations
4Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2Original Research · 2021 · 67 citations
5Serum Neutralizing Activity Elicited by mRNA-1273 VaccineOriginal Research · 2021 · 471 citations